The FDA Recommends Prescribers Discuss Naloxone when Prescribing Opioids

The FDA Recommends Prescribers Discuss Naloxone when Prescribing Opioids

The FDA recommends prescribers discuss naloxone when prescribing opioids or medications to treat opioid use disorder (OUD). In a recent Drug Safety Communication posted on July 23, 2020, the FDA made the recommendations about naloxone in an effort to reduce the risk of death from opioid overdose. Do you know what the FDA is recommending? What steps do you need to take as a prescriber?

Read More
COVID-19 Vaccine Approval: Is the Answer that Easy?

COVID-19 Vaccine Approval: Is the Answer that Easy?

The race to the first Food and Drug Administration (FDA) approved COVID19 vaccine is on, but is the answer that easy? Probably not, but we all have high hopes for returning to the “normal” world we once knew. Although we are all hoping for a one hundred percent effective vaccine with life-long immunity, reality may be completely different.

Read More
New Drug Shortages and the Second Wave of COVID-19

New Drug Shortages and the Second Wave of COVID-19

With new COVID-19 outbreaks occurring across the country and the world, the concern for drug shortages is heightened.  What drugs are impacted and how do they affect your organization?  Do you have a contingency plan in place to deal with unexpected shortages?  Work with your consultant pharmacist to resolve these issues quickly and efficiently so that patient safety and your day-to-day operations are not impacted.

Read More
Happy Father’s Day!

Happy Father’s Day!

This weekend we celebrate Father’s Day.

From the OctariusRx team to all our business associates and friends, we extend warm greetings to all fathers and father figures on the special occasion of Father’s Day.  Here’s to a day full of love and laughter with your family.

 "My father gave me the greatest gift anyone could give another person, he believed in me." ~ Jim Valvano

Read More